Horizon Discovery named ‘most promising’ at conference, 3/13:76

Horizon Discovery was named the most promising company at the Personalized Medicine World Conference 2013. Horizon was chosen from 32 shortlisted companies based on technology, historical performance of the company, and forward business plans.

Horizon’s Genesis genome-editing technology is precise and flexible. With Genesis, any endogenous gene sequence of a human or mammalian cell line can be altered quickly, reliably, and without off-target effects. Horizon has applied Genesis to create more than 500 X-Man isogenic cell lines, accurately modeling the disease-causing mutations found in cancer patients.

Horizon Discovery, 44(0)12 2365 5580